Machine learning and peptide-array experiments reveal new substrates for protein-modifying enzymes
A hybrid workflow coupled machine-learning models with enzyme-treated peptide arrays to predict previously unexplored protein post-translational-modification sites. Experimental validation confirmed 37–43% of proposed sites across SET8 and SIRT1–7; mass spectrometry confirmed dynamic methylation for several SET8 substrates and deacetylation at 64 unique SIRT2 sites. The work also found altered SET8 substrate networks associated with breast-cancer missense mutations.
Technology: Enzyme-specific ML-hybrid substrate prediction models trained from high-throughput peptide-array assays
Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.
Result, AI contribution and limits
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
- Publication status: Peer-reviewed paper
- Test type: direct test
- Tested: Experimental validation confirmed 37–43% of proposed sites across SET8 and SIRT1–7; mass spectrometry confirmed dynamic methylation for several SET8 substrates and deacetylation at 64 unique SIRT2 sites.
- Still unknown: Reported validation rate is 37–43% of proposed sites, so predictions are not uniformly confirmed. Results concern in-vitro enzyme assays and selected sites; disease relevance of the altered SET8 network is not established as a clinical mechanism.
- AI role: Learned enzyme-specific substrate preferences from experimental array measurements and prioritized novel PTM sites for experimental follow-up; this enabled the reported new SET8/SIRT substrate assignments.
Evidence sources: https://www.nature.com/articles/s42004-025-01717-6.pdf
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: linked separately.
Review scope and date are not recorded; source checked does not establish full-text review.
Citations: at percentile 77 of works of the same type, year and subfield (OpenAlex work metrics, 6 citations; as of 15 Nov 2026). Attention, not a measure of correctness; not part of the score.
Editorial assessment: Impact 3/5 · Validation 3/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.
Follow-up and relationships
No follow-up recorded; this is not a claim that no follow-up exists.
Follow-up review scope and date are not recorded.
No source-supported relationships recorded.